These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 10545953)

  • 1. Perlecan is essential for cartilage and cephalic development.
    Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
    Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlecan maintains the integrity of cartilage and some basement membranes.
    Costell M; Gustafsson E; Aszódi A; Mörgelin M; Bloch W; Hunziker E; Addicks K; Timpl R; Fässler R
    J Cell Biol; 1999 Nov; 147(5):1109-22. PubMed ID: 10579729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
    Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
    Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
    Shu CC; Smith SM; Little CB; Melrose J
    Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
    Larraín J; Alvarez J; Hassell JR; Brandan E
    Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis.
    So CL; Kaluarachchi K; Tam PP; Cheah KS
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S160-73. PubMed ID: 11680681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.
    Mathiak M; Yenisey C; Grant DS; Sharma B; Iozzo RV
    Cancer Res; 1997 Jun; 57(11):2130-6. PubMed ID: 9187109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
    Dodge GR; Boesler EW; Jimenez SA
    Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.
    Arikawa-Hirasawa E; Wilcox WR; Yamada Y
    Am J Med Genet; 2001; 106(4):254-7. PubMed ID: 11891676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
    Naski MC; Wang Q; Xu J; Ornitz DM
    Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate of perlecan is involved in glomerular filtration.
    Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
    J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature.
    Belknap JK; Weiser-Evans MC; Grieshaber SS; Majack RA; Stenmark KR
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):24-34. PubMed ID: 9870914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.
    Shung CY; Ota S; Zhou ZQ; Keene DR; Hurlin PJ
    Hum Mol Genet; 2012 Nov; 21(21):4628-44. PubMed ID: 22843502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice.
    Garofalo S; Kliger-Spatz M; Cooke JL; Wolstin O; Lunstrum GP; Moshkovitz SM; Horton WA; Yayon A
    J Bone Miner Res; 1999 Nov; 14(11):1909-15. PubMed ID: 10571691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking link protein develop dwarfism and craniofacial abnormalities.
    Watanabe H; Yamada Y
    Nat Genet; 1999 Feb; 21(2):225-9. PubMed ID: 9988279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.
    Legeai-Mallet L; Benoist-Lasselin C; Munnich A; Bonaventure J
    Bone; 2004 Jan; 34(1):26-36. PubMed ID: 14751560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.